HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: From the CORDIOPREV trial

JOSE LOPEZ MIRANDAFRANCISCO JAVIER DELGADO LISTAPABLO PEREZ MARTINEZ2026-01-292026-01-29201710.1038/s41598-017-12678-92-s2.0-85030549706https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/28472MultidisciplinaryHDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: From the CORDIOPREV trialresearch article